Literature DB >> 4603750

[Polish Society of Internists].

.   

Abstract

Mesh：

Year:  1974        PMID： 4603750

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


× No keyword cloud information.
  5 in total

1.  Advances in Tumor Sampling and Sequencing in Breast Cancer and their Application in Precision Diagnostics and Therapeutics.

Authors:  Amos Chungwon Lee; Han-Byoel Lee; Huiran Yeom; Seo Woo Song; Su Deok Kim; Ahyoun Choi; Sumin Lee; Yongju Lee; Wonshik Han; Sunghoon Kwon
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation.

Authors:  Kai Miao; Josh Haipeng Lei; Monica Vishnu Valecha; Aiping Zhang; Jun Xu; Lijian Wang; Xueying Lyu; Si Chen; Zhengqiang Miao; Xin Zhang; Sek Man Su; Fangyuan Shao; Barani Kumar Rajendran; Jiaolin Bao; Jianming Zeng; Heng Sun; Ping Chen; Kaeling Tan; Qiang Chen; Koon Ho Wong; Xiaoling Xu; Chu-Xia Deng
Journal:  Nat Commun       Date:  2020-06-26       Impact factor: 14.919

3.  E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements.

Authors:  Matthias Christgen; Stephan Bartels; Jana L van Luttikhuizen; Janin Bublitz; Luisa U Rieger; Henriette Christgen; Helge Stark; Bjoern Sander; Ulrich Lehmann; Doris Steinemann; Patrick W B Derksen; Hans Kreipe
Journal:  Mod Pathol       Date:  2020-06-22       Impact factor: 7.842

4.  Shedding of cancer susceptibility candidate 4 by the convertases PC7/furin unravels a novel secretory protein implicated in cancer progression.

Authors:  Stéphanie Duval; Afnan Abu-Thuraia; Islam E Elkholi; Rui Chen; Deeptee Seebun; Janice Mayne; Jean-François Côté; Daniel Figeys; Nabil G Seidah
Journal:  Cell Death Dis       Date:  2020-08-20       Impact factor: 8.469

5.  Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC.

Authors:  Renbo Tan; Haoyang Li; Zhenyu Huang; Yi Zhou; Mingxin Tao; Xin Gao; Ying Xu
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.